Related Experiment Video

Updated: May 5, 2026

In vitro Biofilm Formation in an 8-well Chamber Slide
06:14

In vitro Biofilm Formation in an 8-well Chamber Slide

Published on: January 20, 2011

40.2K

Biofilm Production and Its Implications in Pediatrics

Nicola Principi1, Susanna Esposito2

  • 1Università degli Studi di Milano, 20122 Milan, Italy.

Microorganisms
|August 29, 2024
PubMed

Insights

Bacterial biofilms cause persistent pediatric respiratory infections by resisting antibiotics. New antibiofilm strategies show promise but need clinical trials for effective treatment of childhood diseases.

Area of Science:

  • Pediatric Respiratory Medicine
  • Microbiology
  • Infectious Diseases

Background:

  • Bacterial biofilms contribute to persistent pediatric respiratory infections like otitis media and cystic fibrosis exacerbations.
  • These biofilms, aggregates of bacteria in a self-produced matrix, are linked to recurrent and chronic childhood conditions.
  • Biofilms significantly reduce antibiotic effectiveness, leading to treatment failures and persistent infections.

Purpose of the Study:

  • To review biofilm production by key pediatric respiratory pathogens.
  • To examine biofilm formation mechanisms, antibiotic resistance, and clinical treatment challenges.
  • To discuss emerging antibiofilm strategies and their clinical translation hurdles.

Main Methods:

  • This is a narrative review of existing literature.
  • It synthesizes information on biofilm-producing pathogens in pediatric respiratory infections.
  • It evaluates current and potential antibiofilm therapeutic strategies.

Main Results:

  • Common pediatric respiratory pathogens like *Streptococcus pneumoniae*, *Haemophilus influenzae*, *Pseudomonas aeruginosa*, and *Staphylococcus aureus* form biofilms.
  • Biofilm formation confers significant antibiotic resistance, complicating treatment.
  • Experimental antibiofilm strategies (e.g., N-acetylcysteine, dispersin B, quorum sensing inhibitors) show potential but lack clinical validation.
  • Clinical application of novel antibiofilm strategies in children is currently limited.

Conclusions:

  • Effective management of pediatric respiratory infections requires addressing bacterial biofilms.
  • Translating promising in vitro and animal study findings into clinical practice is essential.
  • Further research, including robust clinical trials and standardized detection methods, is needed to overcome biofilm-related treatment challenges in children.

Keywords:
acute otitis mediaadenoiditisbiofilmcystic fibrosisotitis media with effusionprotracted bacterial bronchitis

More Related Videos

Visualizing the Effects of Sputum on Biofilm Development Using a Chambered Coverglass Model05:03

Visualizing the Effects of Sputum on Biofilm Development Using a Chambered Coverglass Model

Published on: December 14, 2016

8.4K
Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis07:16

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis

Published on: September 20, 2024

906

Related Concept Videos

What are Membranes?01:24

What are Membranes?

A cell's plasma membrane demarcates the cell's borders and determines the nature of its interaction with the environment. Cells exclude certain substances, take in others, and excrete some others in controlled quantities. The plasma membrane must be flexible to allow certain cells, such as red and white blood cells, to change their shape while passing through narrow capillaries. These are the more obvious plasma membrane functions. In addition, the plasma membrane's surface carries...
14.6K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
68
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
73